OCTAGAM

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Finland, France, Croatia, Israel, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug OCTAGAM contains one active pharmaceutical ingredient (API):

1 Immunoglobulins, normal human, IV

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 535300203157311, 535300204153415, 535300205151416, 535300206156411, 535300207152411, 535300208159418
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30307-10-12
Country: EE	Ravimiamet	Identifier(s): 1013881, 1082584, 1082595, 1315662, 1315673, 1315684, 1315695, 1638660, 1638671, 1638682, 1771714, 1771758, 1771769, 1771770, 1814284
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 037992, 157995, 158007, 158018, 158040
Country: FR	Base de données publique des médicaments	Identifier(s): 65492097, 67255976
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 150729, 150738, 194704, 194707, 194710, 194716
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-315670569
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7143, 7144, 7145
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1035690, 1035691, 1035692, 1035693, 1073401, 1073402, 1073403, 1082911, 1086501, 1086502, 1086503, 1086504, 1086505, 1086506, 1086507, 1088909
Country: MT	Medicines Authority	Identifier(s): MA1219/00201, MA1219/00202, MA1219/00203, MA1219/00204, MA1219/00205, MA1219/00601, MA1219/00602, MA1219/00603, MA1219/00604, MA1219/00605, MA1219/00606
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 48062, 48070, 48089, 80055, 80063, 80071, 91308
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 12027
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100080622, 100080639, 100193912, 100222619, 100406160
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65624001, W65624002, W65624003, W65624004, W65624005, W65624006, W65624007, W65903001, W65903002, W65903003, W65903004, W65903005, W65903006, W65903007
Country: SG	Health Sciences Authority	Identifier(s): 10859P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10043021H, 10043022H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699686000002, 8699686000026, 8699686980052, 8699686980090
Country: US	FDA, National Drug Code	Identifier(s): 68982-840, 68982-850
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/30.2/0501